Bone marrow aspirate concentrate (BMAC) is now commonly used in orthopedic surgery. Animal studies showed promising results for cartilage, bone, and soft tissue healing; however, many of these outcomes have yet to be translated to human models. While there has been an increase in the use of BMAC in foot and ankle procedures, the associated clinical evidence is limited. The purpose of this review is to analyze the existing literature in order to evaluate the safety and efficacy of BMAC in foot and ankle surgery.
AdamsSBJrThorpeMAParksBG, et al. Stem cell-bearing suture improves Achilles tendon healing in a rat model. Foot Ankle Int. 2014;35(3):293-299.
2.
AdamsSBLewisJSJrGuptaAK, et al. Cannulated screw delivery of bone marrow aspirate concentrate to a stress fracture nonunion: technique tip. Foot Ankle Int. 2013;34(5):740-744.
3.
AiJEbrahimiSKhoshzabanA, et al. Tissue engineering using human mineralized bone xenograft and bone marrow mesenchymal stem cells allograft in healing of tibial fracture of experimental rabbit model. Iran Red Crescent Med J. 2012;14:96-103.
4.
BarnettMDJPomeroyGC.Use of platelet-rich plasma and bone marrow-derived mesenchymal stem cells in foot and ankle surgery. Tech Foot Ankle Surg. 2007;6:89-94.
5.
CaplanAIDennisJE.Mesenchymal stem cells as trophic mediators. J Cell Biochem. 2006;98:1076-1084.
6.
CassanoJMKennedyJGRossKAFraserEJGoodaleMBFortierLA.Bone marrow concentrate and platelet-rich plasma differ in cell distribution and interleukin 1 receptor antagonist protein concentration. Knee Surg Sports Traumatol Arthrosc. 2018;26:333-342.
7.
ChiodoCPHahneJWilsonMGGlowackiJ.Histological differences in iliac and tibial bone graft. Foot Ankle Int. 2010;31(5):418-422.
8.
ClantonTOJohnsonNSMathenyLM.Use of cartilage extracellular matrix and bone marrow aspirate concentrate in treatment of osteochondral lesions of the talus. Tech Foot Ankle Surg. 2014;13(4):212-220.
9.
ConnollyJGuseRLippielloL, et al. Development of an osteogenic bone-marrow preparation. J Bone Joint Surg Am. 1989;71(5):684-691.
10.
ConnollyJGuseRTiedemanJ, et al. Autologous marrow injection as a substitute for operative grafting of tibial nonunions. Clin Orthop Relat Res. 1991;266:259-270.
11.
CottomJMPlemmonsBS.Bone marrow aspirate concentrate and its uses in the foot and ankle. Clin Podiatr Med Surg. 2018;35(1):19-26.
12.
CourneyaJPLuzinaIGZellerCB, et al. Interleukins 4 and 13 modulate gene expression and promote proliferation of primary human tenocytes. Fibrogenesis Tissue Repair. 2010;3:9.
13.
DaigreJLDeMillSLHyerCF.Assessment of bone marrow aspiration site pain in foot and ankle surgery. Foot Ankle Spec. 2016;9(3):215-217.
14.
DallariDSavarinoLStagniC, et al. Enhanced tibial osteotomy healing with use of bone grafts supplemented with platelet gel or platelet gel and bone marrow stromal cells. J Bone Joint Surg Am. 2007;89(11):2413-2420.
15.
DiGiovanniCWLinSSBaumhauerJF, et al. Recombinant human platelet derived growth factor-BB and beta-tricalcium phosphate (rhPDGF-BB/beta-TCP): an alternative to autogenous bone graft. J Bone Joint Surg Am. 2013;95(13):1184-1192.
16.
DominiciMLe BlancKMuellerI, et al. Minimal criteria for defining multipotent mesenchymal stromal cells: the International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315-317.
17.
FortierLABarkerJUStraussEJMcCarrelTMColeBJ.The role of growth factors in cartilage repair [review]. Clin Orthop Relat Res. 2011;469(10):2706-2715.
18.
FortierLAPotterHGRickeyEJ, et al. Concentrated bone marrow aspirate improves full-thickness cartilage repair compared with microfracture in the equine model. J Bone Joint Surg Am. 2010;92(10):1927-1937.
19.
GangjiVDe MaertelaerVHauzeurJP.Autologous bone marrow cell implantation in the treatment of non-traumatic osteonecrosis of the femoral head: five year follow-up of a prospective controlled study. Bone. 2011;49(5):1005-1009.
20.
GianakosANiAZambranaLKennedyJGLaneJM.Bone marrow aspirate concentrate in animal long bone healing: an analysis of basic science evidence. J Orthop Trauma. 2016;30(1):1-9.
21.
GianniniSBudaRBattagliaM, et al. One-step repair in talar osteochondral lesions: 4-year clinical results and t2-mapping capability in outcome prediction. Am J Sports Med. 2013;41(3):511-518.
22.
GianniniSBudaRVanniniFCavalloMGrigoloB.One-step bone marrow-derived cell transplantation in talar osteochondral lesions. Clin Orthop Relat Res. 2009;467(12):3307-3320.
23.
HannonCPRossKAMurawskiCD, et al. Arthroscopic bone marrow stimulation and concentrated bone marrow aspirate for osteochondral lesions of the talus: a case-control study of functional and magnetic resonance observation of cartilage repair tissue outcomes. Arthroscopy. 2016;32(2):339-347.
24.
HarfordJSDekkerTJAdamsSB.Bone marrow aspirate concentrate for bone healing in foot and ankle surgery. Foot Ankle Clin. 2016;21(4):839-845.
25.
HatzokosIStavridisSIIosifidouEKarataglisDChristodoulouA.Autologous bone marrow grafting combined with demineralized bone matrix improves consolidation of docking site after distraction osteogenesis. J Bone Joint Surg Am. 2011;93(7):671-678.
26.
HegdeVShonugaOEllisS, et al. A prospective comparison of 3 approved systems for autologous bone marrow concentration demonstrated nonequivalency in progenitor cell number and concentration. J Orthop Trauma. 2014;28(10):591-598.
27.
HernigouPDuboryAHommaYFlouzat LachanietteCHChevallierNRouardH.Single-stage treatment of infected tibial non-unions and osteomyelitis with bone marrow granulocytes precursors protecting bone graft. Int Orthop. 2018;42(10):2443-2450.
28.
HernigouPGuissouIHommaY, et al. Percutaneous injection of bone marrow mesenchymal stem cells for ankle non-unions decreases complications in patients with diabetes. Int Orthop. 2015;39(8):1639-1643.
29.
HernigouPHommaYFlouzat LachanietteCH, et al. Benefits of small volume and small syringe for bone marrow aspirations of mesenchymal stem cells. Int Orthop. 2013;37(11):2279-2287.
30.
HernigouPHommaYFlouzat-LachanietteCHPoignardAChevallierNRouardH.Cancer risk is not increased in patients treated for orthopaedic diseases with autologous bone marrow cell concentrate. J Bone Joint Surg Am. 2013;95(24):2215-2221.
31.
HernigouPPoignardABeaujeanFRouardH.Percutaneous autologous bone-marrow grafting for nonunions: influence of the number and concentration of progenitor cells. J Bone Joint Surg Am. 2005;87(7):1430-1437.
32.
HernigouPHMathieuGPoignardA, et al. Percutaneous autologous bone-marrow grafting for nonunions: surgical technique. J Bone Joint Surg. 2006;88A(suppl 1):322.
33.
HoltonJImamMWardJ, et al. The basic science of bone marrow aspirate concentrate in chondral injuries. Orthop Rev (Padvia). 2016;8(3):6659.
34.
HuntKJAndersonRB.Treatment of Jones fracture nonunions and refractures in the elite athlete: outcomes of intramedullary screw fixation with bone grafting. Am J Sports Med. 2011;39(9):1948-1954.
35.
HyerCFBerletGCBussewitzBWHankinsTZieglerHLPhilbinTM.Quantitative assessment of the yield of osteoblastic connective tissue progenitors in bone marrow aspirate from the iliac crest, tibia, and calcaneus. J Bone Joint Surg Am. 2013;95:1312-1316.
36.
JägerMHertenMFochtmannU, et al. Bridging the gap: bone marrow aspiration concentrate reduces autologous bone grafting in osseous defects. J Orthop Res. 2011;29:173-180.
37.
KennedyJGMurawskiCD.The treatment of osteochondral lesions of the talus with autologous osteochondral transplantation and bone marrow aspirate concentrate: surgical technique. Cartilage. 2011;2(4):327-336.
38.
KimGBSeoMSParkWTLeeGW.Bone marrow aspirate concentrate: its uses in osteoarthritis. Int J Mol Sci. 2020;21(9):3224.
39.
KimYSLeeHJChoiYJKimYIKohYG.Does an injection of a stromal vascular fraction containing adipose-derived mesenchymal stem cells influence the outcomes of marrow stimulation in osteochondral lesions of the talus? A clinical and magnetic resonance imaging study. Am J Sports Med. 2014;42:2424-2434.
40.
LanhamNSCarrollJJCooperMT, et al. A comparison of outcomes of particulated juvenile articular cartilage and bone marrow aspirate concentrate for articular cartilage lesions of the talus. Foot Ankle Spec. 2016;10(4):315-321.
41.
LiCKilpatrickCDSmithS, et al. Assessment of multipotent mesenchymal stromal cells in bone marrow aspirate from human calcaneus. J Foot Ankle. 2017;56(1):42-46.
42.
MarxRETursunR.A qualitative and quantitative analysis of autologous human multipotent adult stem cells derived from three anatomic areas by marrow aspiration: tibia, anterior ilium, and posterior ilium. Int J Oral Maxillofac Implants. 2013;28(5):e290-e294.
43.
McCarrelTFortierL.Temporal growth factor release from platelet-rich plasma, trehalose lyophilized platelets, and bone marrow aspirate and their effect on tendon and ligament gene expression. J Orthop Res. 2009;27:1033-1042.
44.
McCrightBDangJMHurshDA, et al. Synopsis of the Food and Drug Administration–National Institute of Standards and Technology co-sponsored “In Vitro Analyses of Cell/Scaffold Products” Workshop. Tissue Eng Part A. 2009;15(3):455-460.
45.
McIlwraithCWFrisbieDDRodkeyWG, et al. Evaluation of intra-articular mesenchymal stem cells to augment healing of microfractured chondral defects. Arthroscopy. 2011;27:1552-1561.
46.
McLainRFFlemingJEBoehmCAMuschlerGF.Aspiration of osteoprogenitor cells for augmenting spinal fusion: comparison of progenitor cell concentrations from the vertebral body and iliac crest. J Bone Joint Surg Am. 2005;87(12):2655-2661.
47.
MurawskiCDKennedyJG.Percutaneous internal fixation of proximal fifth metatarsal jones fractures (zones II and III) with Charlotte Carolina screw and bone marrow aspirate concentrate: an outcome study in athletes. Am J Sports Med. 2011;39(6):1295-1301.
48.
MuschlerGFNittoHBoehmCAEasleyKA.Age- and gender-related changes in the cellularity of human bone marrow and the prevalence of osteoblastic progenitors. J Orthop Res. 2001;19:117-125.
49.
O’MalleyMDeSandisBAllenA, et al. Operative treatment of fifth metatarsal jones fractures (zones II and III) in the NBA. Foot Ankle Int. 2016;37(5):488-500.
50.
PinzurMS.Use of platelet-rich concentrate and bone marrow aspirate in high-risk patients with Charcot arthropathy of the foot. Foot Ankle Int. 2009;30:124-127.
51.
PittengerMFMackayAMBeckSC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284(5411):143-147.
52.
RoukisTSHyerCFPhilbinTMBerletGCLeeTH.Complications associated with autogenous bone marrow aspirate harvest from the lower extremity: an observational cohort study. J Foot Ankle Surg. 2009;48:668-671.
53.
RushSMHamiltonGAAckersonLM.Mesenchymal stem cell allograft in revision foot and ankle surgery: a clinical and radiographic analysis. J Foot Ankle Surg. 2009;48:163-169.
54.
SakaiSMishimaHIshiiT, et al. Concentration of bone marrow aspirate for osteogenic repair using simple centrifugal methods. Acta Orthop. 2008;79(3):445-448.
55.
SawKYHussinPLokeSC, et al. Articular cartilage regeneration with autologous marrow aspirate and hyaluronic acid: an experimental study in a goat model. Arthroscopy. 2009;25(12):1391-1400.
56.
SchadeVRoukisT.Percutaneous bone marrow aspirate and bone graft harvesting techniques in the lower extremity. Clin Podiatr Med Surg. 2008;25(4):733-742.
57.
SchweinbergerMRoukisT.Percutaneous autologous bone-marrow harvest from the calcaneus and proximal tibia: surgical technique. J Foot Ankle Surg. 2007;46(5):411-414.
58.
ShimozonoYYasuiYHurleyETPaughRADeyerTWKennedyJG.Concentrated bone marrow aspirate may decrease postoperative cyst occurrence rate in autologous osteochondral transplantation for osteochondral lesions of the talus. Arthroscopy. 2019;35(1):99-105.
59.
SteinBEStrohDASchonLC.Outcomes of acute Achilles tendon rupture repair with bone marrow aspirate concentrate augmentation. Int Orthop. 2015;39(5):901-905.
60.
UdehiyaRKAmarpalAAithalHP, et al. Comparison of autogenic and allogenic bone marrow derived mesenchymal stem cells for repair of segmental bone defects in rabbits. Res Vet Sci. 2013;94:743-752.
61.
UrdzikovaLMSedlacekRSuchyT, et al. Human multipotent mesenchymal stem cells improve healing after collagenase tendon injury in the rat. Biomed Eng Online. 2014;13:42.
62.
WehlingPMoserCFrisbieD, et al. Autologous conditioned serum in the treatment of orthopaedic diseases: the orthokine therapy. BioDrugs. 2007;21:323-332.
63.
YamaguchiYKuboTMurakamiT, et al. Bone marrow cells differentiate into wound myofibroblasts and accelerate the healing of wounds with exposed bones when combined with an occlusive dressing. Br J Dermatol. 2005;152(4):616-627.
64.
YaoJWoonCYBehnA, et al. The effect of suture coated with mesenchymal stem cells and bioactive substrate on tendon repair strength in a rat model. J Hand Surg Am. 2012;37:1639-1645.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
